Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Ablation Versus Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation

NCT07424326 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT07424326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07424326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Ablation Versus Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation
Lead sponsor
Charles University, Czech Republic
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2026
Completion date
December 31, 2029
Enrollment
450 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af)